<I>Development of regenerated cardiomyocyte for the cardiovascular tissue engineering</I>

  • Fukuda Keiichi
    Institute for Advanced Cardiac Therapeutics, Keio University School of Medicine
  • Hakuno Daihiko
    Cardiopulmonary Division, Department of Internal Medicine, Keio University School of Medicine
  • Konishi Fusako
    Cardiopulmonary Division, Department of Internal Medicine, Keio University School of Medicine
  • Makino Shinji
    Cardiopulmonary Division, Department of Internal Medicine, Keio University School of Medicine
  • Tomita Yuichi
    Cardiopulmonary Division, Department of Internal Medicine, Keio University School of Medicine
  • Ogawa Satoshi
    Cardiopulmonary Division, Department of Internal Medicine, Keio University School of Medicine

Bibliographic Information

Other Title
  • 心血管Tissue engineeringを目指した再生心筋細胞の開発

Search this article

Abstract

We have isolated a cardiomyogenic cell line (CMG cell) from murine bone marrow stromal cells. Stromal cells were immortalized, treated with 5-azacytidine, and spontaneous beating cells were repeatedly screened for. The cells showed a f ibroblast-like morphology, but the morphology changed after 5-azacytidine treatment in approximately 30% of the cells : they connected with adjoining cells after 1 week, formed myotube-like structures and began spontaneous beating after 2 weeks, and beat synchronously after 3 weeks. They expressed ANP and BNP. Electron microscopy revealed a cardiomyocyte-like ultrastructure including typical sarcomeres and atrial granules. These cells had several types of action potentials : sinus node like and ventricular cell-like action potentials. All cells had a long action potential duration or plateau, a relatively shallow resting membrane potential, and a pacemaker-like late diastolic slow depolarization. Analysis of the isoform of contractile protein genes, such as myosin heavy chain, myosin light chain and α-actin, indicated that their muscle phenotype was similar to fetal ventricular cardiomyocytes. These cells expressed Nkx 2.5/Csx, GATA 4, TEF-1 and MEF-2 C mRNA before 5-azacytidine treatment, and expressed MEF-2 A and MEF-2 D after treatment. This new cell line provides a powerful model for the study of cardiomyocyte differentiation.

Journal

  • Ensho Saisei

    Ensho Saisei 21 (6), 639-644, 2001

    The Japanese Society of Inflammation and Regeneration

Citations (1)*help

See more

References(11)*help

See more

Details 詳細情報について

Report a problem

Back to top